• Login
    View Item 
    •   MMUST Institutional Repository
    • University Journals/ Articles
    • Gold Collection
    • View Item
    •   MMUST Institutional Repository
    • University Journals/ Articles
    • Gold Collection
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Functional Haplotypes in the ADIPOQ Gene are Associated with Underweight, Immunosuppression and Viral Suppression in Kenyan HIV-1 Infected Antiretroviral Treatment Naive and Experienced Injection Substance Users

    Thumbnail
    View/Open
    Functional Haplotypes in the ADIPOQ Gene are Associated with Underweight.pdf (290.1Kb)
    Functional Haplotypes in the ADIPOQ Gene are Associated with Underweight.pdf (290.1Kb)
    Date
    2020-07-01
    Author
    Shaviya, Nathan
    Budambula, Valentine
    Were, Tom
    Metadata
    Show full item record
    Abstract
    Background Human immunodeficiency virus and injection substance use have an influence on genes and gene expression. These effects could be beneficial or detrimental in defining disease outcomes. Adiponectin gene is key in modulating metabolic and immunoregulatory functions. Understanding the effects of human immunodeficiency virus and injection substance use on the gene in the context of antiretroviral therapy is important for predicting disease outcomes. Methods This cross-sectional genetic study determined polymorphisms in the promoter region of adiponectin gene. Two variants were analyzed: rs2241766 and rs266729. Polymorphisms were associated with clinical markers of disease outcome; underweight, immunosuppression and viral suppression. The variants were genotyped via random fragment length polymorphism. Result GC haplotype was associated with higher odds of having underweight (OR, 2.21; 95% CI, 1.83–4.60; P=0.008 vs. OR, 2.30; 95% CI, 1.89–4.71; P=0.006) in antiretroviral treatment - naive and experienced injection substance users and immunosuppression (OR, 1.90; 95% CI 1.67–3.98, P=0.041) in naive. Bonferroni correction revealed GC haplotype carriers only to have low body mass index in both naive (median, 14.8; IQR, 3.2 kg/m2; P=0.002) and experienced (median, 15.2; IQR, 3.2 kg/m2; P=0.002) injection substance users. Circulating total adiponectin levels were higher in naive (median, 19.5; IQR, 7.9 µg/ml) than - experienced (median, 12.0; IQR, 4.4 µg/ml) injection substance users (P=0.0001). GC carriers presented with low serum adiponectin levels in both study groups.
    URI
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054454/
    https://www.10.4314/ejhs.v30i4.4
    http://r-library.mmust.ac.ke/123456789/1580
    Collections
    • Gold Collection [990]

    MMUST Library copyright © 2011-2022  MMUST Open Access Policy
    Contact Us | Send Feedback
     

     

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    MMUST Library copyright © 2011-2022  MMUST Open Access Policy
    Contact Us | Send Feedback